Novel function of MKP-5/DUSP10, a phosphatase of stress-activated kinases, on ERK-dependent gene expression, and upregulation of its gene expression in colon carcinomas

Chang L and Karin M: Mammlian MAP kinase signalling cascades. Nature. 410:37–40. 2001.

Boutros T, Chevet E and Metrakos P: Mitogen-activated protein (MAP) kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev. 60:261–310. 2008.

Owens DM and Keyse SM: Differential regulation of MAP kinase signaling by dual-specificity protein phosphatases. Oncogene. 26:3203–3213. 2007.

Keyse SM: Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 27:253–261. 2008.

Haagenson KK and Wu GS: Miotogen activated protein kinase phosphatases and cancer. Cancer Biol Ther. 9:337–340. 2010.

Bermudez O, Pages G and Gimond C: The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physiol. 299:C189–C202. 2010.

Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 9:537–549. 2009.

Tanoue T, Moriguchi T and Nishida E: Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J Biol Chem. 274:19949–19956. 1999.

Theodosiou A, Smith A, Gillieron C, et al: MKP5, a new member of the MKP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases. Oncogene. 18:6981–6988. 1999.

Masuda K, Shima H, Watanabe M and Kikuchi K: MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein. J Biol Chem. 276:39002–39011. 2001.

Masuda K, Shima H, Kikuchi K, et al: Expression and comparative chromosomal mapping of MKP-5 genes DUSP10/Dusp10. Cytogenet Cell Genet. 90:71–74. 2000.

Bar-Shira A, Rashi-Elkeles S, Zlochover L, et al: ATM-dependent activation of the gene encoding MAP kinase phosphatase 5 by radiomimetic DNA damage. Oncogene. 21:849–855. 2002.

Gobert RP, Joubert L, Curchod ML, et al: Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol Cell Biol. 29:1538–1553. 2009.

Katagiri C, Masuda K, Urano T, et al: Phosphorylation of Ser-446 determines stability of MKP-7. J Biol Chem. 280:14716–14722. 2005.

Katagiri C, Masuda K, Nomura M, et al: DUSP13B/TMDP inhibits stress-activated MAPKs and suppresses AP-1-dependent gene expression. Mol Cell Biochem. 352:155–162. 2011.

Todd JL, Tanner KG and Denu JM: Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. J Biol Chem. 274:13271–13280. 1999.

Brown MD and Sacks DB: Protein scaffolds in MAP kinase signaling. Cell Signal. 21:462–469. 2009.

Ebisuya M, Kondoh K and Nishida E: The duration, magnitude and compartmentalization of ERK MAPK kinase activity: mechanisms for providing signaling specificity. J Cell Sci. 118:2997–3002. 2005.

Formstecher E, Ramos JW, Fauquet M, et al: PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell. 1:239–250. 2001.

Nonn L, Peng L, Feldman D and Peehl DM: Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: Implication for prostate cancer prevention by vitamin D. Cancer Res. 66:4516–4524. 2006.

Nonn L, Duong D and Peelh DM: Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis. 28:1188–1196. 2007.

Fichera A, Little N and Bissonnette MA: Vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. Surg Res. 142:239–245. 2007.